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1726-4Sowing the seeds of health: Is the era of food prescriptions
coming?In the past few decades, there is an astonishing amount of
accumulated evidence that indicates that natural compounds
extracted from plants exertdat least in vitrodsignificant
effects against many pathological conditions. The term “phy-
tochemical” has been introduced, which is defined as bioactive
chemicals in fruits, vegetables, grains, and various plants that
may provide health benefits.1 A mechanism for this is that
phytochemicals provide antioxidant defenses that ameliorate
DNA oxidation and affect cellular signal transduction path-
ways controlling cell proliferation and apoptosis.1 In human
studies, consuming fruits and vegetables at greater than the
average amount is associated with the reduced risk of diseases
such as cardiovascular disease and malignancy.2 Another study
reports that the sum of different flavonoid intake (e.g., quer-
cetin, myricetin, kaempferol, luteolin, and ficetin) was inver-
sely correlated with plasma total cholesterol concentration and
low-density lipoprotein cholesterol concentration.3
One remarkable advantage of using natural products as
pharmaceuticals is their relatively low toxicity or lack of
toxicity within a wide range of dosages, which contributes to
a better success rate on entering into a Phase I trial, compared
to conventional chemicals (25% vs. 6%, respectively).4
Therefore, it can be speculated whether it is possible to
actually control diseases with phytochemicals. Several
ongoing concerns should lead investigators to proceed with
caution as relevant data are considered. A concern is the
extent to which success in animal studies can be applied to
clinical practice.
Experiments on animals provide crucial background and
necessary information, which enhance the execution and
efficacy of clinical trials. However, a compound or ingredient
that is effective for animals may not work in human patients.
The most straightforward but often overlooked factor can be
the lack of appropriate dose extrapolation from animal
experiments to human application. The dose calculation
should not be based merely on body weight. The Food and
Drug Administration of the United States has actually sug-
gested that the extrapolation of animal dose to human dose is
correctly performed only through normalization to body sur-
face area.5
The second concern is that the yield of phytochemicals
from plants can be limited because of technical issues orx.doi.org/10.1016/j.jcma.2014.04.001
901/Copyright  2014 Elsevier Taiwan LLC and the Chinese Medical Assbecause the amount of the available plant is restricted by
special cultivation requirements. To solve these potential
problems, in vitro reconstruction and biosynthesis have been
developed.6
A third concern is the low bioavailability of some phy-
tochemicals. In fact, some antioxidants do not appear to have
consistent benefits in large-scale human studies.7 In one
clinical trial, the incidence of malignant cancers was
unchanged in patients taking a b-carotene supplement.8 The
isolated pure compound either loses its bioactivity or may not
provide the anticipated benefit when delivered in food form.
For instance, different species of fruits have a variety of
phytochemical profiles.9 The additive and synergistic effects
of phytochemicals may be pivotal factors that account for their
potent antioxidant activities. A recent survey revealed that
apple phytochemical extracts and quercetin 3-beta-D-gluco-
side used in combination exert a synergistic effect against
MCF-7 human breast cancer cell proliferation.10 This there-
fore suggests that, although routine clinical prescription of a
single phytochemical is becoming more feasible as a way to
prevent or cure disease, people should obtain phytochemicals
from a wide variety of fruits, vegetables, and whole grains for
balanced health benefits. It is indeed inevitable that multiple
intrinsic and extrinsic factors such as storage time, genetic
factors, physiological factors, and the impact of cooking have
strong influences on the content and bioactivities of phy-
tochemicals among different kinds of foods.11,12
In this issue, two remarkable studies that focus on the
effects of phytochemicals are presented. Tarik Mohammed
Chaouche et al13 revealed the total phenolic, flavonoid, and
tannin contents of three Algerian medicinal plants (Echium
pycnanthum Pomel, Haloxylon articulatum Boiss, and Sol-
enostemma oleifolium Bull. & Bruce). They found that these
South Algerian plants possess high in vitro antioxidant
potency, which may be feasible for applied medicinal purposes
in humans.13 In another study, Ai-Ren Zuo et al14 examined
the hepatoprotective effects of phloretin and phloretin iso-
nicotinyl hydrazone (PIH) on D-galactosamine-induced acute
liver damage in mice. The results revealed that phloretin or
PIH administration significantly ameliorated serum bio-
chemistry abnormalities and histological changes in acute liver
damage. Phloretin and PIH also exhibited antioxidant effectsociation. All rights reserved.
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scavenging activity in vitro, and supercoiled pBR322 plasmid
DNA. Furthermore, a good antityrosinase activity was also
present. Phloretin is a type of apple-derived flavonoid that has
antioxidant properties. Phloretin isonicotinyl hydrazone is a
novel compound synthesized by the same group; it exerts a
higher level of antioxidant activity than phloretin.15 These
investigations show the characteristics and benefits of various
phytochemicals in vitro and in animal models. In fact, human
trials are anticipated to ascertain their clinical potential.
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